Europe Clinical Trials Market size is expected to reach USD 20.2 billion by 2030
Europe Clinical Trials Industry Overview The Europe clinical trials market size was valued at USD 12.2 billion in 2021 and is anticipated to exhibit a compound annual growth rate (CAGR) of 5.7% from 2022 to 2030. Growing demand for personalized medicines in the region due to significant research funding for personalized therapies by public organizations is the prime factor driving the market in the region. The technological advances for clinical trials have significantly improved in recent years, further exhibiting a positive impact on the market. Apart from this, the COVID-19 pandemic had created an urgent demand for COVID-19 therapeutics and diagnostic devices which has significantly improved the demand for clinical trials in the region. Gather more insights about the market drivers, restrains and growth of the Europe Clinical Trials Market A significant number of people in the region suffer from chronic diseases. For instance, the Robert Koch Inst...